|
|
muscle structure development
|
GO:0061061 |
196 |
0.501
|
|
|
|
specification of symmetry
|
GO:0009799 |
204 |
0.489
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
110 |
0.462
|
|
|
|
heart development
|
GO:0007507 |
313 |
0.456
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
108 |
0.416
|
|
|
|
muscle tissue development
|
GO:0060537 |
110 |
0.358
|
|
|
|
response to alkaloid
|
GO:0043279 |
2 |
0.350
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
179 |
0.305
|
|
|
|
heart morphogenesis
|
GO:0003007 |
156 |
0.303
|
|
|
|
ion transport
|
GO:0006811 |
114 |
0.263
|
|
|
|
regulation of rna biosynthetic process
|
GO:2001141 |
213 |
0.251
|
|
|
|
embryonic organ development
|
GO:0048568 |
381 |
0.231
|
|
|
|
immune system process
|
GO:0002376 |
241 |
0.229
|
|
|
|
regulation of rna metabolic process
|
GO:0051252 |
224 |
0.219
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
91 |
0.202
|
|
|
|
aromatic compound biosynthetic process
|
GO:0019438 |
217 |
0.200
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
2 |
0.190
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
3 |
0.188
|
|
|
|
signal transduction
|
GO:0007165 |
455 |
0.187
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
191 |
0.180
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
139 |
0.173
|
|
|
|
female sex differentiation
|
GO:0046660 |
4 |
0.172
|
|
|
|
macromolecule biosynthetic process
|
GO:0009059 |
227 |
0.167
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
133 |
0.164
|
|
|
|
regulation of response to stimulus
|
GO:0048583 |
269 |
0.162
|
|
|
|
determination of bilateral symmetry
|
GO:0009855 |
204 |
0.158
|
|
|
|
nucleic acid templated transcription
|
GO:0097659 |
181 |
0.157
|
|
|
|
transmembrane transport
|
GO:0055085 |
120 |
0.152
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
274 |
0.149
|
|
|
|
cation transport
|
GO:0006812 |
81 |
0.141
|
|
|
|
heart looping
|
GO:0001947 |
94 |
0.139
|
|
|
|
regulation of cellular biosynthetic process
|
GO:0031326 |
245 |
0.136
|
|
|
|
regulation of cellular macromolecule biosynthetic process
|
GO:2000112 |
222 |
0.135
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
48 |
0.134
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
117 |
0.132
|
|
|
|
regulation of nucleobase containing compound metabolic process
|
GO:0019219 |
250 |
0.126
|
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
223 |
0.123
|
|
|
|
rna biosynthetic process
|
GO:0032774 |
181 |
0.122
|
|
|
|
regulation of system process
|
GO:0044057 |
40 |
0.116
|
|
|
|
blood vessel development
|
GO:0001568 |
246 |
0.114
|
|
|
|
transcription dna templated
|
GO:0006351 |
181 |
0.113
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
107 |
0.113
|
|
|
|
heterocycle biosynthetic process
|
GO:0018130 |
215 |
0.112
|
|
|
|
heterocycle metabolic process
|
GO:0046483 |
290 |
0.110
|
|
|
|
gene expression
|
GO:0010467 |
252 |
0.110
|
|
|
|
cell surface receptor signaling pathway
|
GO:0007166 |
325 |
0.108
|
|
|
|
positive regulation of transport
|
GO:0051050 |
2 |
0.108
|
|
|
|
regulation of transcription dna templated
|
GO:0006355 |
213 |
0.108
|
|
|
|
immune system development
|
GO:0002520 |
191 |
0.107
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
50 |
0.104
|
|
|
|
regulation of gene expression
|
GO:0010468 |
265 |
0.098
|
|
|
|
head development
|
GO:0060322 |
303 |
0.098
|
|
|
|
rna metabolic process
|
GO:0016070 |
219 |
0.096
|
|
|
|
biosynthetic process
|
GO:0009058 |
294 |
0.095
|
|
|
|
circulatory system process
|
GO:0003013 |
87 |
0.095
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
57 |
0.094
|
|
|
|
cellular nitrogen compound biosynthetic process
|
GO:0044271 |
218 |
0.085
|
|
|
|
positive regulation of biological process
|
GO:0048518 |
253 |
0.085
|
|
|
|
convergent extension
|
GO:0060026 |
118 |
0.085
|
|
|
|
regulation of signaling
|
GO:0023051 |
235 |
0.085
|
|
|
|
vasculature development
|
GO:0001944 |
278 |
0.083
|
|
|
|
nucleic acid metabolic process
|
GO:0090304 |
244 |
0.082
|
|
|
|
tube morphogenesis
|
GO:0035239 |
349 |
0.081
|
|
|
|
nucleobase containing compound biosynthetic process
|
GO:0034654 |
205 |
0.081
|
|
|
|
regulation of developmental process
|
GO:0050793 |
247 |
0.080
|
|
|
|
regulation of macromolecule biosynthetic process
|
GO:0010556 |
225 |
0.079
|
|
|
|
positive regulation of nitrogen compound metabolic process
|
GO:0051173 |
69 |
0.079
|
|
|
|
homeostatic process
|
GO:0042592 |
142 |
0.078
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
69 |
0.078
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
148 |
0.078
|
|
|
|
organic substance biosynthetic process
|
GO:1901576 |
289 |
0.076
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
1 |
0.076
|
|
|
|
nucleobase containing compound metabolic process
|
GO:0006139 |
274 |
0.075
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
1 |
0.075
|
|
|
|
regulation of cell communication
|
GO:0010646 |
232 |
0.074
|
|
|
|
regulation of nitrogen compound metabolic process
|
GO:0051171 |
251 |
0.074
|
|
|
|
cellular biosynthetic process
|
GO:0044249 |
286 |
0.073
|
|
|
|
metal ion transport
|
GO:0030001 |
58 |
0.072
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
4 |
0.071
|
|
|
|
multi organism process
|
GO:0051704 |
134 |
0.070
|
|
|
|
developmental pigmentation
|
GO:0048066 |
48 |
0.070
|
|
|
|
cardiac chamber formation
|
GO:0003207 |
4 |
0.069
|
|
|
|
single organism organelle organization
|
GO:1902589 |
199 |
0.069
|
|
|
|
organic cyclic compound metabolic process
|
GO:1901360 |
301 |
0.068
|
|
|
|
segmentation
|
GO:0035282 |
97 |
0.068
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
12 |
0.067
|
|
|
|
system process
|
GO:0003008 |
185 |
0.067
|
|
|
|
response to external stimulus
|
GO:0009605 |
264 |
0.066
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
1 |
0.065
|
|
|
|
nitrogen compound metabolic process
|
GO:0006807 |
319 |
0.065
|
|
|
|
negative regulation of transcription dna templated
|
GO:0045892 |
45 |
0.065
|
|
|
|
cellular macromolecule biosynthetic process
|
GO:0034645 |
224 |
0.064
|
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
129 |
0.064
|
|
|
|
establishment of localization
|
GO:0051234 |
244 |
0.063
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
87 |
0.062
|
|
|
|
organelle assembly
|
GO:0070925 |
110 |
0.058
|
|
|
|
regulation of nucleic acid templated transcription
|
GO:1903506 |
213 |
0.058
|
|
|
|
regionalization
|
GO:0003002 |
274 |
0.057
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
4 |
0.057
|
|
|
|
mesenchyme development
|
GO:0060485 |
127 |
0.057
|
|
|
|
negative regulation of cellular process
|
GO:0048523 |
283 |
0.057
|
|
|
|
positive regulation of nucleic acid templated transcription
|
GO:1903508 |
57 |
0.057
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
1 |
0.057
|
|
|
|
regulation of metabolic process
|
GO:0019222 |
359 |
0.056
|
|
|
|
forebrain development
|
GO:0030900 |
96 |
0.056
|
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
77 |
0.056
|
|
|
|
female gonad development
|
GO:0008585 |
4 |
0.056
|
|
|
|
cellular aromatic compound metabolic process
|
GO:0006725 |
295 |
0.054
|
|
|
|
eye morphogenesis
|
GO:0048592 |
144 |
0.054
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
78 |
0.053
|
|
|
|
positive regulation of biosynthetic process
|
GO:0009891 |
68 |
0.053
|
|
|
|
positive regulation of rna biosynthetic process
|
GO:1902680 |
57 |
0.053
|
|
|
|
regulation of synapse assembly
|
GO:0051963 |
3 |
0.053
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
32 |
0.053
|
|
|
|
transcription from rna polymerase ii promoter
|
GO:0006366 |
80 |
0.053
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
24 |
0.052
|
|
|
|
cellular component movement
|
GO:0006928 |
335 |
0.052
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
216 |
0.051
|
|
|
|
regulation of biological quality
|
GO:0065008 |
263 |
0.051
|
|
|
|
regulation of multicellular organismal process
|
GO:0051239 |
277 |
0.050
|
|
|
|
regulation of behavior
|
GO:0050795 |
24 |
0.050
|
|
|
|
muscle cell development
|
GO:0055001 |
115 |
0.049
|
|
|
|
negative regulation of metabolic process
|
GO:0009892 |
86 |
0.049
|
|
|
|
locomotion
|
GO:0040011 |
313 |
0.049
|
|
|
|
negative regulation of biological process
|
GO:0048519 |
304 |
0.049
|
|
|
|
positive regulation of rna metabolic process
|
GO:0051254 |
59 |
0.048
|
|
|
|
sleep
|
GO:0030431 |
1 |
0.048
|
|
|
|
negative regulation of gene expression
|
GO:0010629 |
65 |
0.048
|
|
|
|
single organism localization
|
GO:1902578 |
225 |
0.048
|
|
|
|
stem cell differentiation
|
GO:0048863 |
117 |
0.048
|
|
|
|
cellular macromolecule metabolic process
|
GO:0044260 |
391 |
0.048
|
|
|
|
organic cyclic compound biosynthetic process
|
GO:1901362 |
223 |
0.047
|
|
|
|
lipid catabolic process
|
GO:0016042 |
4 |
0.047
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
4 |
0.046
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
65 |
0.044
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
4 |
0.044
|
|
|
|
vasculogenesis
|
GO:0001570 |
41 |
0.044
|
|
|
|
cell death
|
GO:0008219 |
121 |
0.044
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
1 |
0.043
|
|
|
|
estrogen metabolic process
|
GO:0008210 |
2 |
0.043
|
|
|
|
positive regulation of muscle organ development
|
GO:0048636 |
1 |
0.043
|
|
|
|
death
|
GO:0016265 |
121 |
0.043
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
3 |
0.043
|
|
|
|
negative regulation of reproductive process
|
GO:2000242 |
3 |
0.043
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
2 |
0.043
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
2 |
0.042
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
4 |
0.042
|
|
|
|
compound eye development
|
GO:0048749 |
2 |
0.042
|
|
|
|
regulation of macromolecule metabolic process
|
GO:0060255 |
317 |
0.042
|
|
|
|
regulation of cellular metabolic process
|
GO:0031323 |
320 |
0.042
|
|
|
|
central nervous system development
|
GO:0007417 |
387 |
0.041
|
|
|
|
hemopoiesis
|
GO:0030097 |
183 |
0.041
|
|
|
|
regulation of transmembrane transporter activity
|
GO:0022898 |
2 |
0.041
|
|
|
|
transport
|
GO:0006810 |
220 |
0.040
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
122 |
0.040
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
65 |
0.040
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
54 |
0.040
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
195 |
0.040
|
|
|
|
circadian sleep wake cycle process
|
GO:0022410 |
2 |
0.039
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
2 |
0.039
|
|
|
|
axis specification
|
GO:0009798 |
43 |
0.039
|
|
|
|
single organism transport
|
GO:0044765 |
206 |
0.039
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
2 |
0.039
|
|
|
|
cognition
|
GO:0050890 |
1 |
0.039
|
|
|
|
organonitrogen compound metabolic process
|
GO:1901564 |
74 |
0.038
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
4 |
0.038
|
|
|
|
circadian sleep wake cycle sleep
|
GO:0050802 |
1 |
0.038
|
|
|
|
regulation of sequestering of calcium ion
|
GO:0051282 |
4 |
0.038
|
|
|
|
regulation of transcription from rna polymerase ii promoter
|
GO:0006357 |
114 |
0.038
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
10 |
0.038
|
|
|
|
cellular nitrogen compound metabolic process
|
GO:0034641 |
290 |
0.037
|
|
|
|
positive regulation of gene expression
|
GO:0010628 |
71 |
0.037
|
|
|
|
negative regulation of rna metabolic process
|
GO:0051253 |
48 |
0.036
|
|
|
|
striated muscle cell development
|
GO:0055002 |
108 |
0.036
|
|
|
|
negative regulation of response to stimulus
|
GO:0048585 |
104 |
0.035
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
3 |
0.035
|
|
|
|
oxoacid metabolic process
|
GO:0043436 |
31 |
0.035
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
80 |
0.034
|
|
|
|
cardiac atrium morphogenesis
|
GO:0003209 |
2 |
0.034
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
30 |
0.034
|
|
|
|
negative regulation of biosynthetic process
|
GO:0009890 |
55 |
0.033
|
|
|
|
regulation of protein binding
|
GO:0043393 |
3 |
0.033
|
|
|
|
neuron differentiation
|
GO:0030182 |
353 |
0.033
|
|
|
|
blood circulation
|
GO:0008015 |
87 |
0.033
|
|
|
|
regulation of tube size
|
GO:0035150 |
2 |
0.033
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
3 |
0.033
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
32 |
0.033
|
|
|
|
chemical homeostasis
|
GO:0048878 |
49 |
0.032
|
|
|
|
larval development
|
GO:0002164 |
2 |
0.032
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
28 |
0.032
|
|
|
|
maintenance of location
|
GO:0051235 |
4 |
0.032
|
|
|
|
sensory organ development
|
GO:0007423 |
393 |
0.032
|
|
|
|
negative regulation of macromolecule metabolic process
|
GO:0010605 |
76 |
0.032
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
42 |
0.031
|
|
|
|
protein targeting to nucleus
|
GO:0044744 |
3 |
0.031
|
|
|
|
heart process
|
GO:0003015 |
71 |
0.031
|
|
|
|
behavior
|
GO:0007610 |
74 |
0.031
|
|
|
|
positive regulation of transcription dna templated
|
GO:0045893 |
57 |
0.031
|
|
|
|
negative regulation of stem cell differentiation
|
GO:2000737 |
2 |
0.031
|
|
|
|
positive regulation of macromolecule biosynthetic process
|
GO:0010557 |
59 |
0.030
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
333 |
0.029
|
|
|
|
negative regulation of rna biosynthetic process
|
GO:1902679 |
45 |
0.029
|
|
|
|
positive regulation of cellular metabolic process
|
GO:0031325 |
94 |
0.029
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
4 |
0.029
|
|
|
|
positive regulation of nucleobase containing compound metabolic process
|
GO:0045935 |
69 |
0.029
|
|
|
|
regulation of biosynthetic process
|
GO:0009889 |
250 |
0.029
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
7 |
0.028
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
4 |
0.028
|
|
|
|
neuron development
|
GO:0048666 |
262 |
0.027
|
|
|
|
peptide metabolic process
|
GO:0006518 |
1 |
0.027
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
2 |
0.027
|
|
|
|
locomotor rhythm
|
GO:0045475 |
3 |
0.027
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
4 |
0.027
|
|
|
|
circadian sleep wake cycle
|
GO:0042745 |
2 |
0.027
|
|
|
|
regulation of response to biotic stimulus
|
GO:0002831 |
2 |
0.027
|
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
4 |
0.027
|
|
|
|
localization of cell
|
GO:0051674 |
244 |
0.027
|
|
|
|
negative regulation of cellular macromolecule biosynthetic process
|
GO:2000113 |
48 |
0.026
|
|
|
|
embryonic cranial skeleton morphogenesis
|
GO:0048701 |
90 |
0.026
|
|
|
|
cell migration
|
GO:0016477 |
237 |
0.026
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
53 |
0.026
|
|
|
|
heart field specification
|
GO:0003128 |
1 |
0.026
|
|
|
|
negative regulation of macromolecule biosynthetic process
|
GO:0010558 |
48 |
0.026
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
142 |
0.026
|
|
|
|
regulation of organ growth
|
GO:0046620 |
3 |
0.025
|
|
|
|
glomerulus development
|
GO:0032835 |
27 |
0.025
|
|
|
|
positive regulation of canonical wnt signaling pathway
|
GO:0090263 |
4 |
0.025
|
|
|
|
regulation of growth
|
GO:0040008 |
42 |
0.024
|
|
|
|
organic acid metabolic process
|
GO:0006082 |
31 |
0.024
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
3 |
0.024
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
9 |
0.024
|
|
|
|
intracellular signal transduction
|
GO:0035556 |
85 |
0.024
|
|
|
|
regulation of neurotransmitter transport
|
GO:0051588 |
1 |
0.023
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
7 |
0.023
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
2 |
0.023
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
60 |
0.023
|
|
|
|
negative regulation of cellular biosynthetic process
|
GO:0031327 |
55 |
0.023
|
|
|
|
regulation of synapse organization
|
GO:0050807 |
3 |
0.023
|
|
|
|
positive regulation of cellular biosynthetic process
|
GO:0031328 |
68 |
0.023
|
|
|
|
phagocytosis
|
GO:0006909 |
3 |
0.023
|
|
|
|
regulation of binding
|
GO:0051098 |
3 |
0.022
|
|
|
|
regulation of primary metabolic process
|
GO:0080090 |
311 |
0.022
|
|
|
|
specification of organ identity
|
GO:0010092 |
2 |
0.022
|
|
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
3 |
0.022
|
|
|
|
single organism metabolic process
|
GO:0044710 |
217 |
0.022
|
|
|
|
cardiac conduction
|
GO:0061337 |
3 |
0.022
|
|
|
|
protein import
|
GO:0017038 |
3 |
0.022
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
106 |
0.021
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
2 |
0.021
|
|
|
|
protein complex assembly
|
GO:0006461 |
30 |
0.021
|
|
|
|
negative regulation of nucleic acid templated transcription
|
GO:1903507 |
45 |
0.021
|
|
|
|
cell fate specification
|
GO:0001708 |
68 |
0.021
|
|
|
|
regulation of heart growth
|
GO:0060420 |
2 |
0.021
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
9 |
0.021
|
|
|
|
cellular component biogenesis
|
GO:0044085 |
178 |
0.020
|
|
|
|
organelle organization
|
GO:0006996 |
227 |
0.020
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
30 |
0.020
|
|
|
|
negative regulation of nitrogen compound metabolic process
|
GO:0051172 |
59 |
0.020
|
|
|
|
synaptic target recognition
|
GO:0008039 |
1 |
0.020
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
18 |
0.020
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
2 |
0.020
|
|
|
|
ventricular cardiac muscle cell differentiation
|
GO:0055012 |
6 |
0.020
|
|
|
|
positive regulation of macromolecule metabolic process
|
GO:0010604 |
93 |
0.020
|
|
|
|
connective tissue development
|
GO:0061448 |
99 |
0.020
|
|
|
|
lipid homeostasis
|
GO:0055088 |
3 |
0.020
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
2 |
0.020
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
23 |
0.020
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
20 |
0.019
|
|
|
|
gall bladder development
|
GO:0061010 |
1 |
0.019
|
|
|
|
neuron projection morphogenesis
|
GO:0048812 |
161 |
0.019
|
|
|
|
nephron development
|
GO:0072006 |
31 |
0.019
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
58 |
0.019
|
|
|
|
positive regulation of metabolic process
|
GO:0009893 |
108 |
0.019
|
|
|
|
cellular component assembly
|
GO:0022607 |
170 |
0.019
|
|
|
|
response to nutrient
|
GO:0007584 |
3 |
0.019
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
1 |
0.019
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
2 |
0.019
|
|
|
|
adult behavior
|
GO:0030534 |
2 |
0.019
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
3 |
0.019
|
|
|
|
gtp catabolic process
|
GO:0006184 |
2 |
0.019
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
3 |
0.019
|
|
|
|
regulation of cell activation
|
GO:0050865 |
1 |
0.019
|
|
|
|
antimicrobial humoral response
|
GO:0019730 |
2 |
0.019
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
2 |
0.018
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
72 |
0.018
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
86 |
0.018
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
2 |
0.018
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
3 |
0.018
|
|
|
|
response to chemical
|
GO:0042221 |
320 |
0.018
|
|
|
|
apoptotic process
|
GO:0006915 |
116 |
0.018
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
3 |
0.018
|
|
|
|
positive regulation of heart contraction
|
GO:0045823 |
2 |
0.018
|
|
|
|
aging
|
GO:0007568 |
2 |
0.018
|
|
|
|
regulation of protein transport
|
GO:0051223 |
3 |
0.018
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
1 |
0.018
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
33 |
0.018
|
|
|
|
regulation of signal transduction
|
GO:0009966 |
225 |
0.017
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
4 |
0.017
|
|
|
|
renal system development
|
GO:0072001 |
94 |
0.017
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
3 |
0.017
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
53 |
0.017
|
|
|
|
myofibril assembly
|
GO:0030239 |
48 |
0.017
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
2 |
0.017
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
2 |
0.017
|
|
|
|
negative regulation of signaling
|
GO:0023057 |
96 |
0.017
|
|
|
|
heart contraction
|
GO:0060047 |
71 |
0.017
|
|
|
|
response to other organism
|
GO:0051707 |
97 |
0.017
|
|
|
|
generation of neurons
|
GO:0048699 |
385 |
0.017
|
|
|
|
response to stress
|
GO:0006950 |
263 |
0.017
|
|
|
|
regulation of ion transport
|
GO:0043269 |
22 |
0.017
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
7 |
0.017
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
23 |
0.017
|
|
|
|
cellular localization
|
GO:0051641 |
97 |
0.017
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
3 |
0.016
|
|
|
|
calcium ion import
|
GO:0070509 |
4 |
0.016
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
4 |
0.016
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
4 |
0.016
|
|
|
|
appendage development
|
GO:0048736 |
80 |
0.016
|
|
|
|
response to hypoxia
|
GO:0001666 |
25 |
0.016
|
|
|
|
skeletal system development
|
GO:0001501 |
181 |
0.016
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
3 |
0.016
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
4 |
0.016
|
|
|
|
dorsal ventral pattern formation
|
GO:0009953 |
125 |
0.016
|
|
|
|
regulation of localization
|
GO:0032879 |
104 |
0.016
|
|
|
|
developmental growth
|
GO:0048589 |
166 |
0.016
|
|
|
|
cell proliferation involved in heart morphogenesis
|
GO:0061323 |
2 |
0.016
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
1 |
0.016
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
2 |
0.016
|
|
|
|
cell projection organization
|
GO:0030030 |
284 |
0.016
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
1 |
0.016
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
1 |
0.016
|
|
|
|
gland development
|
GO:0048732 |
143 |
0.015
|
|
|
|
startle response
|
GO:0001964 |
4 |
0.015
|
|
|
|
aorta development
|
GO:0035904 |
4 |
0.015
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
2 |
0.015
|
|
|
|
hormone secretion
|
GO:0046879 |
2 |
0.015
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
85 |
0.015
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
46 |
0.015
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
3 |
0.015
|
|
|
|
renal system process involved in regulation of systemic arterial blood pressure
|
GO:0003071 |
1 |
0.015
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
336 |
0.015
|
|
|
|
proteolysis
|
GO:0006508 |
38 |
0.015
|
|
|
|
brain development
|
GO:0007420 |
293 |
0.015
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
21 |
0.015
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
3 |
0.015
|
|
|
|
axon development
|
GO:0061564 |
166 |
0.015
|
|
|
|
digestive tract development
|
GO:0048565 |
265 |
0.015
|
|
|
|
carboxylic acid metabolic process
|
GO:0019752 |
22 |
0.015
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
52 |
0.015
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
130 |
0.015
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
2 |
0.015
|
|
|
|
positive regulation of gliogenesis
|
GO:0014015 |
2 |
0.015
|
|
|
|
response to carbohydrate
|
GO:0009743 |
3 |
0.014
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
2 |
0.014
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
79 |
0.014
|
|
|
|
synaptic growth at neuromuscular junction
|
GO:0051124 |
2 |
0.014
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
2 |
0.014
|
|
|
|
muscle organ development
|
GO:0007517 |
101 |
0.014
|
|
|
|
pigment cell differentiation
|
GO:0050931 |
38 |
0.014
|
|
|
|
angiogenesis
|
GO:0001525 |
158 |
0.014
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
246 |
0.014
|
|
|
|
cation homeostasis
|
GO:0055080 |
33 |
0.014
|
|
|
|
regulation of cell death
|
GO:0010941 |
103 |
0.014
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
4 |
0.014
|
|
|
|
regulation of molecular function
|
GO:0065009 |
70 |
0.014
|
|
|
|
positive regulation of striated muscle cell differentiation
|
GO:0051155 |
1 |
0.014
|
|
|
|
cardiac atrium development
|
GO:0003230 |
4 |
0.014
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
200 |
0.014
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
7 |
0.014
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
2 |
0.014
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
2 |
0.014
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter
|
GO:0045944 |
22 |
0.014
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
3 |
0.014
|
|
|
|
oxidation reduction process
|
GO:0055114 |
41 |
0.014
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
2 |
0.014
|
|
|
|
positive regulation of multi organism process
|
GO:0043902 |
3 |
0.014
|
|
|
|
sensory perception of pain
|
GO:0019233 |
1 |
0.013
|
|
|
|
atrial cardiac muscle cell development
|
GO:0055014 |
4 |
0.013
|
|
|
|
endocardial cushion formation
|
GO:0003272 |
2 |
0.013
|
|
|
|
positive regulation of response to stimulus
|
GO:0048584 |
80 |
0.013
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
3 |
0.013
|
|
|
|
amide biosynthetic process
|
GO:0043604 |
1 |
0.013
|
|
|
|
cell morphogenesis
|
GO:0000902 |
289 |
0.013
|
|
|
|
anterior posterior pattern specification
|
GO:0009952 |
152 |
0.013
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
1 |
0.013
|
|
|
|
autophagy
|
GO:0006914 |
4 |
0.013
|
|
|
|
gtp metabolic process
|
GO:0046039 |
4 |
0.013
|
|
|
|
cell morphogenesis involved in neuron differentiation
|
GO:0048667 |
163 |
0.013
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
1 |
0.013
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
1 |
0.013
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
4 |
0.013
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
1 |
0.013
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
1 |
0.013
|
|
|
|
endocardial cushion morphogenesis
|
GO:0003203 |
3 |
0.013
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
3 |
0.012
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
8 |
0.012
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
2 |
0.012
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
23 |
0.012
|
|
|
|
regulation of skeletal muscle tissue development
|
GO:0048641 |
4 |
0.012
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
1 |
0.012
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
244 |
0.012
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
4 |
0.012
|
|
|
|
cardiac conduction system development
|
GO:0003161 |
1 |
0.012
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
4 |
0.012
|
|
|
|
tissue remodeling
|
GO:0048771 |
4 |
0.012
|
|
|
|
action potential
|
GO:0001508 |
19 |
0.012
|
|
|
|
amine metabolic process
|
GO:0009308 |
2 |
0.012
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
0 |
0.012
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
2 |
0.012
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
1 |
0.012
|
|
|
|
single organism nuclear import
|
GO:1902593 |
3 |
0.012
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
116 |
0.012
|
|
|
|
atrioventricular valve formation
|
GO:0003190 |
3 |
0.012
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
56 |
0.012
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
13 |
0.012
|
|
|
|
lipid storage
|
GO:0019915 |
1 |
0.012
|
|
|
|
small molecule metabolic process
|
GO:0044281 |
77 |
0.012
|
|
|
|
chemotaxis
|
GO:0006935 |
104 |
0.012
|
|
|
|
response to bacterium
|
GO:0009617 |
58 |
0.012
|
|
|
|
protein polymerization
|
GO:0051258 |
4 |
0.012
|
|
|
|
determination of ventral identity
|
GO:0048264 |
21 |
0.012
|
|
|
|
stem cell development
|
GO:0048864 |
82 |
0.012
|
|
|
|
cellular homeostasis
|
GO:0019725 |
26 |
0.011
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
2 |
0.011
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
8 |
0.011
|
|
|
|
endocrine process
|
GO:0050886 |
2 |
0.011
|
|
|
|
mesenchymal cell proliferation
|
GO:0010463 |
1 |
0.011
|
|
|
|
gastrulation with mouth forming second
|
GO:0001702 |
44 |
0.011
|
|
|
|
cell death in response to oxidative stress
|
GO:0036473 |
2 |
0.011
|
|
|
|
long chain fatty acid metabolic process
|
GO:0001676 |
1 |
0.011
|
|
|
|
cellular response to starvation
|
GO:0009267 |
1 |
0.011
|
|
|
|
response to endogenous stimulus
|
GO:0009719 |
83 |
0.011
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
1 |
0.011
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
25 |
0.011
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
2 |
0.011
|
|
|
|
negative regulation of mitosis
|
GO:0045839 |
3 |
0.011
|
|
|
|
neuromast development
|
GO:0048884 |
46 |
0.011
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
2 |
0.011
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
2 |
0.011
|
|
|
|
negative regulation of sequestering of calcium ion
|
GO:0051283 |
4 |
0.011
|
|
|
|
positive regulation of cell division
|
GO:0051781 |
2 |
0.011
|
|
|
|
positive regulation of jak stat cascade
|
GO:0046427 |
2 |
0.011
|
|
|
|
cardiac ventricle formation
|
GO:0003211 |
1 |
0.011
|
|
|
|
organic substance transport
|
GO:0071702 |
58 |
0.011
|
|
|
|
neurological system process
|
GO:0050877 |
62 |
0.011
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
2 |
0.011
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
23 |
0.011
|
|
|
|
muscle fiber development
|
GO:0048747 |
52 |
0.011
|
|
|
|
positive regulation of molecular function
|
GO:0044093 |
33 |
0.011
|
|
|
|
macromolecule modification
|
GO:0043412 |
111 |
0.011
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
79 |
0.011
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
1 |
0.011
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
4 |
0.011
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
4 |
0.011
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
51 |
0.011
|
|
|
|
somitogenesis
|
GO:0001756 |
87 |
0.011
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
2 |
0.011
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
1 |
0.011
|
|
|
|
macromolecular complex assembly
|
GO:0065003 |
35 |
0.011
|
|
|
|
cell motility
|
GO:0048870 |
244 |
0.011
|
|
|
|
pronephros development
|
GO:0048793 |
69 |
0.011
|
|
|
|
peptide transport
|
GO:0015833 |
1 |
0.010
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
3 |
0.010
|
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
2 |
0.010
|
|
|
|
cardiac cell fate commitment
|
GO:0060911 |
1 |
0.010
|
|
|
|
stem cell maintenance
|
GO:0019827 |
4 |
0.010
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
48 |
0.010
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
1 |
0.010
|
|
|
|
regulation of developmental growth
|
GO:0048638 |
38 |
0.010
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
29 |
0.010
|
|
|
|
regulation of cell development
|
GO:0060284 |
100 |
0.010
|
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
3 |
0.010
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
68 |
0.010
|
|
|
|
regulation of transport
|
GO:0051049 |
45 |
0.010
|
|
|
|
negative regulation of mesodermal cell fate specification
|
GO:0042662 |
3 |
0.010
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
3 |
0.010
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
2 |
0.010
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
0 |
0.010
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
2 |
0.010
|
|
|
|
fin development
|
GO:0033333 |
77 |
0.010
|
|
|
|
phagocytosis engulfment
|
GO:0006911 |
1 |
0.010
|
|
